Travere Therapeutics TVTX Earnings Call Transcripts

NASDAQ TVTX
$51.99 +0.36 (+0.70%)
At close: Nov 10, 2026 · 4:00 PM EST
7 earnings calls on file for Travere Therapeutics, from Q4 2019 to Q3 2026. Each transcript opens in a new tab.
Latest earnings call

Travere Therapeutics Q3 2026 Earnings Call

Nov 2, 2026 8,870 words · 39 min read
  • Eric DubePresident and Chief Executive Officer
  • Peter HeermaChief Commercial Officer
  • Jula InrigHead of R&D and Chief Medical Officer
  • Christopher ClineChief Financial Officer
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

Travere Therapeutics Earnings Call Transcripts

Calls7
LatestNov 2, 2026
SinceQ4 2019

Fiscal 2026

Fiscal 2025

Fiscal 2020

Fiscal 2019

All 7 Travere Therapeutics transcripts Register to get access to Travere Therapeutics’s earnings call transcripts.